Nuvasive Inc Watch

from 8-K 5 pages First Supplemental Indenture

from 8-K 97 pages Nuvasive, Inc. and Wilmington Trust, National Association Trustee Indenture Dated as of June 1, 2020 1.00% Convertible Senior Notes Due 2023

from 8-K 99 pages Nuvasive, Inc. and Wilmington Trust, National Association Trustee Indenture Dated as of March 2, 2020 0.375% Convertible Senior Notes Due 2025

from 10-K 3 pages Description of Capital Stock

from 8-K 101 pages Nuvasive, Inc. and Wilmington Trust, National Association Trustee Indenture Dated as of March 16, 2016 2.25% Convertible Senior Notes Due 2021

from S-3ASR 17 pages Stock Sale Plan Agreement

from 8-K 86 pages Nuvasive, Inc. and U.S. Bank National Association Trustee Indenture Dated as of June 28, 2011 2.75% Convertible Senior Notes Due 2017

from S-3ASR 85 pages Nuvasive, Inc. and U.S. Bank National Association Trustee Indenture Dated as of [ ] [ ]% Convertible Senior Notes Due [ ]

from S-3ASR 11 pages A-1 Nuvasive, Inc. [ ]% Convertible Senior Notes Due [ ]

from 10-Q 30 pages Nuvasive, Inc. 2.25% Convertible Senior Notes Due 2013 Registration Rights Agreement

from 10-Q 16 pages The Sale of This Security Has Not Been Registered Under the United States Securities Act of 1933, as Amended (The “Securities Act”), and Accordingly, This Security May Not Be Offered or Sold Except as Set Forth in the Following Sentence. by Its Acquisition Hereof, the Holder Agrees (1) That It Will Not Within the Later of (X) One Year After the Latest Issue Date of This Security and (Y) Three Months After It Ceases to Be an Affiliate (Within the Meaning of Rule 144 Under the Securities Act) of the Issuer, Offer, Resell, Pledge or Otherwise Transfer the Security Evidenced Hereby or the Common Stock Issuable Upon Conversion of Such Security, Except (A) to the Issuer; (B) Under a Registration Statement That Has Been Declared Effective Under the Securities Act; (C) to a Person the Seller Reasonably Believes Is a Qualified Institutional Buyer (As Defined in Rule 144a Under the Securities Act) That Is Purchasing for Its Own Account or for the Account of Another Qualified Institutional Buyer and to Whom Notice Is Given That the Transfer Is Being Made in Reliance on Rule 144a, All in Compliance With Rule 144a (If Available); or (D) Under Any Other Available Exemption From the Registration Requirements of the Securities Act; and (2) That It Will, Prior to Any Transfer of This Security Within the Later of (X) One Year After the Latest Issue Date of This Security and (Y) Three Months After It Ceases to Be an Affiliate (Within the Meaning of Rule 144 Adopted Under the Securities Act) of the Issuer, Furnish to the Trustee and the Issuer Such Certifications, Legal Opinions or Other Information as May Be Required Pursuant to the Indenture to Confirm That Such Transfer Is Being Made Pursuant to an Exemption From, or in a Transaction Not Subject To, the Registration Requirements of the Securities Act. in Any Event, No Affiliate of the Issuer May Purchase or Sell This Security

from 10-Q 98 pages Nuvasive, Inc. and U.S. Bank National Association Trustee Indenture Dated as of March 7, 2008 2.25% Convertible Senior Notes Due 2013 Certain Sections of This Indenture Relating to Sections 310 Through 318 of the Trust Indenture Act of 1939

from 8-K 4 pages Registration Rights Agreement Termination Agreement

from 10-K 3 pages Additional Abbreviations May Also Be Used Though Not in the Above List

from 8-K 15 pages Registration Rights Agreement

from S-1/A 3 pages Control No

from S-1 ~10 pages Nuvasive, Inc. Amendment No. 2 to Second Amended and Restated Investors' Rights Agreement

from S-1 ~10 pages Nuvasive, Inc. Amendment No. 1 to Second Amended and Restated Investors' Rights Agreement

from S-1 ~20 pages Nuvasive, Inc. Second Amended and Restated Investors' Rights Agreement July 11, 2002